Skip to main content

Table 2 Human cell lines utilized for the present study

From: Development of aqueous-based multi-herbal combination using principal component analysis and its functional significance in HepG2 cells

S. No.

Cells

Tissue origin

Malignancy

Cell doubling time

1.

A-549

Lung

Carcinoma

~ 22 h

2.

HeLa

Cervix

Adenocarcinoma

~ 25 h

3.

IMR-32

Sympathetic nervous system

Neuroblastoma

~ 20 h

4.

HepG2

Liver

Hepatocellular carcinoma

~ 48 h

5.

MG-63

Bone

Osteosarcoma

~ 28 h

6.

293 T

Embryonic kidney

Non-malignant

~ 27 h